Johnson & Johnson's (JNJ) results show the firm's ability to offset generic and branded competition, says Damien Conover. He and David Toung recap JNJ's earnings. They talk about how the 4Q international sales came in at $11.19B and 4Q worldwide consumer sales came in at $3.77B. They then go over the key takeaways from JNJ's earnings. Tune in to find out more about the stock market today.
25 Jan 2023
Morning Trade Live
18 Oct 2023
The Watch List
12 Sep 2023
The Watch List
20 Oct 2023
Market On Close
10 Nov 2023
Trading 360
02 Nov 2023
Market On Close
01 Dec 2023